“KILLING THE GOOSE THAT
LAYS THE GOLDEN EGGS.
selected British politicians, including European Parliamentarians.
Chair’ of the U.K. Pharmaceutical ‘Cartel’.
So without the government’s continued willingness to fund supplies to users, there would be no incentive for the industry.
but not the layout, just as we received it:
(N.B. ‘G.T.L.G.’ likely means:
“Goose That Lays Golden”)
Dear Friends and Colleagues,
incorporation of the revisions agreed upon by the Committee at the end
of our recent week-end conference.
The twin goals of the plan remain unchanged. Namely:
i) that our industry and its allies will be the only authorised suppliers, producers, distributors and purveyors of all drugs entering and consumed in the U.K. drugs marketplace, and
ii) that the market is to be continuously expanded by all possible international, national and local strategies.
1) The main aims of the plan are therefore confirmed as:
a) To take total control of the supply, production, distribution, marketing and sale of all drugs consumed in the U.K. drugs marketplace.
b) To maintain current turnover levels whilst working towards a continuing expansion of the main forms of drug use – medical, behavioural control and recreational.
c) To maximise the financial contribution of government towards the costs of supplying drugs to a majority of the using population, and,
d) To ensure that all those organisations and programmes, likely to impede a), b) & c) above, are effectively immobilised or side-lined.
2) Because 1a) & b) above include all currently illicit drugs, then the legalisation of all illicit drugs is a primary target of our policies. This will not only avoid competition from illegal suppliers by placing the supplying of all drugs under our ethical control, but will also expand usage of such drugs at competitive prices.
3) Because 1a) above also includes those legally licensed and / or prescribed drugs over which we already exercise control, every effort is being made to avoid the entry and / or expansion into the marketplace of alternative natural or nutritional substances from non-pharmaceutical producers. At the same time research on less controversial replacements for the flagging benzo ranges also continues.
4) The requirement under 1a) above, for us to take total control of the U.K. drugs marketplace, has of course resulted in a necessity for us to be able to equally control or strongly influence the Department of Health, the Home Office, the Department for Education and Skills, the British Medical Association and the Royal Pharmaceutical Society amongst others.
This in turn has given us considerable influence over the National Health Service, H.M.Prison Service, the Probationary Service, the National Treatment Agency, the AdvisoryCouncil on the Misuse of Drugs, and the Drug Prevention Advisory Service.
Much of the credit for this good work must go to the amalgamation and re-organisingof DrugScope by Roger Howard which, combined with the influence of our friends at Alcohol Concern (who share offices with DrugScope), and our psychiatric colleaguesat Denmark Hill, is now achieving very significant influence over all those sectors of U.K establishment decision-making directly or indirectly concerned with the control or usage of drugs of all types. The Drug Education Practitioners Forum, the PoliceFoundation, Liberty, the National Children’s Forum, Release and Transform are but a few excellent examples of our indirect influence over more numerous groups.
Amongst other successes, DrugScope now virtually controls the All Party Parliamentary Drugs Misuse Group, the National Drugs Help-Line and various Ministers, and because of these allies and other contacts was able to be by far the biggest contributor of evidence to the Home Affairs Select Committee.
5) Because 1b) above includes the maintenance of current turnover levels, all forms of cure or rehabilitation treatment (other than those based on the use of habit management drugs) must eventually be legislated out of operation.
Civil servants and successive UK governments have been fully convinced, by our psychiatric colleagues and our expanding DrugScope PR operation, that drug addiction is an incurable congenital mental condition which ‘fortunately’ psychiatrists and other physicians can manage in the community with pharmacological treatments.
As a consequence we will continue to use our psychiatric and government departmental connections to ensure that all treatment must be on a maintenance basis prescribing regular doses (normally daily) of habit management drugs – mainly paid for by the taxpayer via the NHS.
6) Because 1b) above also includes expansion, in order to maintain the flow of new users entering the marketplace, all efforts at effective prevention training by other organisations continue to be ridiculed, ‘exposed’ and generally side-lined by DrugScope and their libertarian allies so as to rob them of funding. The main aim of our strategy will continue to be our development of youth and child drug use by all means possible. The young are much easier to influence and of course have a longer ’customer life’ than adults.
We will therefore continue to reinforce those of our marketing operations directed at UK youth and their parents. ‘Harm reduction’, ‘informed choice’, ‘responsible drug use’ and ‘safe drug use’ will thus remain the main planks in school PR campaigns. This drug education agenda promotes drug usage as basically inevitable, and so essentially permits it on an apparently controlled basis. Some members expressed concern that ‘prevention’ training was again expanding in the schools system, but a recent DrugScope report to the Committee described the start (in DrugScope’s Associated DrugLink magazine) of a successful media attack on two main prevention organisations – NDPA and NN. Details of further funding for this work were also agreed. (See financial report attached.)
7) Because of the demand for expansion and government financial contribution expressed in both 1b) and 1c) above, there must also be a reinforcement of direct psychiatric medical intervention in UK schools, based on the prescription of Prozac, Ritalin and other behavioural control drugs to suitably selected children.
New psychiatric illnesses recently developed and published in the American Psychiatric Association Diagnostic & Statistical Manual of Mental Disorders are paving the way to the introduction of further drugs into our schools prescription programme.
Steps are also being taken to introduce the same new psychiatrically sponsored conditions into the Mental and Behavioural Disorders Section of the next edition of the World Health Organisation ICD (the International Statistical Classification of Diseases and Related Health Problems).
Distribution of behavioural control drugs by prescription to selected groups is possibly our most valuable programme currently running. We avoid the costly and fragmented process of marketing to individuals, each newly enrolled education authority or school bringing us worthwhile numbers of new patients for which government pays. And because we start at the bottom of the age range, each user has the maximum customer life ahead of him, whilst up to the age of 16 within the schools system we enjoy direct control over each patient.
8) Because 1c) above requires the maximisation of the financial contribution of government towards the cost of supplying drugs to a majority of the using population, the treatment of existing and new problem drug users must be kept in psycho-pharmaceutical hands in order to ensure maximum turnover of addiction management drugs such as methadone, buprenorphine and naltrexone, etc.
As a result, funds for recent plans by the government to increase the number of places for rehabilitation of drug users must be kept in the hands of those providers of treatment based exclusively on the administration of habit management drugs. As these were essentially Trace contacts and as he could still be useful, the idea is being fostered amongst them and elsewhere that he was given a very raw deal.
In addition our PR people will continue to cultivate Drug Action Team Co-ordinators and Chairmen, to ensure that the DAT funds are not misdirected into other non psycho-pharmacological channels.
In this regard, the National Treatment Agency’s nearly completed “Models of Care” plan intended to eliminate (officially) all non-pharmacological treatments – is about to start achieving this second stage of what we expected from DrugScope’s covert development of this agency.
By having as the first stage a senior DrugScope employee appointed as the Agency’s establishment-phase Director of Personnel, the goal of having a government agency staffed nearly exclusively by allies was fully achieved.
Fortunately, the Mike Trace fiasco has done little to upset our plans for the NTA as he was already destined for the international scene.
However it is clear that something must be done about MP and SD at the Mail, who must be brought into line with their other press colleagues.
9) Because 1d) calls for the immobilisation of organisations and programmes likely to impede 1a), b) & c) above, and because the most likely threats will come
i) from prevention based training programmes and
ii) from vitamin based and other abstinence therapies, such programmes and therapies must be obstructed not only by black media campaigns, but also by appropriate UK and European legislation.
Prevention based training programmes for schoolchildren (as well as PTAs) will soon be handled into obscurity by the ‘Blueprint’ plan, which is being developed by a regional director of the Home Office Drug Prevention Advisory service. Here again we are fortunate to have a DrugScope trained ally in a sensitive and influential post, so that drug education in ‘harm reduction’, ‘informed choice’, ‘responsible drug use’ and ‘safe drug use’ will; soon become an integral and unassailable part of DfES curricula. At the same time, our continuing derision of ‘prevention training’ will again ensure that such prevention programmes receive no official funding and that they will also be looked upon as politically incorrect by charitable and other fund providers.
The vitamin based and other abstinence therapies are being handled in two ways. The NTA Models of Care plan will essentially authorise only our psycho-pharmacological treatments. Those treatments which do not base themselves on the dispensing of habit management and / or other drugs will thus be deprived of official funding.
Additionally the work already under way in Brussels and Strasbourg, for outlawing large dose format natural vitamin supplies, will not only soon start bringing these non-conforming treatments to a halt, but will also put the European and UK supplying of vitamins into our hands on a small dose profitable daily supply basis retailed only by established high street chemists and other allied or controlled pharmaceutical outlets.
10) The National Treatment Outcome Research Study (NTORS) being carried out by our Denmark Hill psychiatric colleagues has of course been proving successful at holding political curiosity at bay for a considerable time, and the final fifth year report is now due for publication – if it is not already circulating as a confidential pre-release briefing to our various allies in the bureaucracy.
Whilst from a technical viewpoint it is expected to have a mixed reception in certain quarters, along with CARAT and DT&TOs, it has achieved its basic PR objectives and provided the time necessary to develop the NTA and to see our further entrenchment in the Drug Action Team (DAT) network. This has been made even more vital by the recent government channelling of new and additional drug treatment finance via the various DATS, and DrugScope have outlined their plans for maximising control of this spending via the NTA.
11) Payments to physicians for prescribing drugs possibly harmful to the patient (such as methadone) are still needed to persuade reluctant G.Ps to ‘assess’ the value of these products to their local community. Members should therefore ensure that their local NHS and political contacts are fully aware that these payments are vital to current drug treatment modalities, even though item 12) below may eventually be helpful in this regard.
12) The project for the public to be able to purchase prescription drugs – without need of a prescription – over the internet is going according to plan, with these new sales now beginning to escalate, and thus far there has been no government protest or action from any of the countries being reached.
Members wishing to examine the excellent prices this method of distribution can command may do so by visiting the outlet at firstname.lastname@example.org. They should also bear in mind that because such supplies are direct to the public, all the mark-ups and margins on this distribution line accrue directly to the manufacturing companies supplying the products.
Clearly a new form of distribution which also gives greater consumer control, as a result of which reports on such trading will now be issued monthly to members.
13) For those interested, transcripts of the main papers presented at the conference are available to Committee Members, as follows:
* A) Liberalisation, Decriminalisation and Legalisation Plans and Progress.
* B) The DrugScope Annual Progress Report and Update.
* C) Plans to Take Advantage of the Impending NTORS Completion (and for a parallel long- term follow-up campaign in the drug education sector).
* D) The Latest from the Denmark Hill Diary and Other Psychiatric Allies.
* E) Networking Within the WHO, the NGOs and Europe.
* F) New Product Design Directions & Opportunities Amongst the Young.
* G) Beyond the Benzos. Opportunities Amongst Adults and the Elderly.
* H) Improving Political and Media Control – U.K. Ally Entertaining Plans.
* I) Covert Conference Support Plans – Current & Future Financing.
* J) Useful Individuals and Organisations – Who to Contact for What.
* K) Mergers – Is Inter Company Co-operation Now Making them Obsolete?
* L) The Magic Bullet – Why a Search for Addiction Cures is Not Advised.
* M) Financing Our Fifth Column Allies. (Mike Trace and Co’s New Roles.)
* N) The UK’s Role in Europe and Vice Versa – Plans for Vienna.
* O) Raw Material Supplies: Is buying from the Drug Barons the Answer?
* P) The NHS and the NTA – Can the Tail Wag the Dog?
* Q) Security: Recent Threats and Proposals for their Handling.
14) I would respectfully remind Members that the current quarter’s ‘Protection and Expansion Fund’ donations are due with me not later than the last day of this month and year, and I would in any event like to report that these are all to hand at the next scheduled meeting with GS’s Open Society Institute.
15) Finally: Our Next Committee Meeting:
The suggested venue is again Berchtesgaden, and the month is March. As agreed at the conference, I await lists of two acceptable March weekends from each Member to enable me to finalise a date convenient to a majority.
J. S. C. Chairman.
(end of memo received by The Sprout, ourselves and numerous others)
Bearing in mind that, contrary to what their PR says, pharmaceutical companies are not charities . . . . what is your verdict?
1) Can this “confidential” memo really be some form of practical joke? Jokers love an audience and usually stay around for the laughs and for their applause, so why has the writer not made him or her self known and claimed the credit?
2) Can this “confidential” memo perhaps be a hoax perpetrated by someone with a genuine grudge against the pharmaceutical industry and psychiatry? We know that many involuntary addicts (and others like “The Prozac Victims Group”) who were prescribed into addiction, do hold rather large grudges - with what they consider to be good reason - against the psycho-pharmaceutical fraternity. But these are most often quite elderly ladies on tranquillisers, benzos, etc., who would not normally have the intimate knowledge of the drug scene demonstrated by the writer of that memo.
3) Can this “confidential” memo be a fictitious document written by some anonymous senior employee experienced in, but disillusioned with, the psycho-pharm industry, who feels that the guilt of his employers can no longer be hidden and that it must be exposed so that something humanely effective can be done about it?
4) Or can this “confidential” memo perhaps be a copy of a real inter-committee memo the contents of which some such employee felt had to be “whistle-blown” for the greater good of the community at large.
Most observers feel it came from the third or fourth possible source indicated above but that more importantly, it does reveal a genuine state of affairs which must be addressed !
S.A.F.E. Is A Not-For-Profit Community Support Group Formed In 1975,